Jiangsu Nhwa Pharmaceutical Co Ltd
SZSE:002262
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
21.36
28.12
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Jiangsu Nhwa Pharmaceutical Co Ltd
Net Margin
Jiangsu Nhwa Pharmaceutical Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | CN |
| Market Cap | 27.1B CNY |
| Net Margin |
21%
|
| Country | JP |
| Market Cap | 776 550.9T JPY |
| Net Margin |
-79%
|
| Country | US |
| Market Cap | 749.7B USD |
| Net Margin |
20%
|
| Country | UK |
| Market Cap | 440.4B GBP |
| Net Margin |
-4%
|
| Country | DK |
| Market Cap | 3.4T DKK |
| Net Margin |
35%
|
| Country | US |
| Market Cap | 372B USD |
| Net Margin |
17%
|
| Country | US |
| Market Cap | 257.3B USD |
| Net Margin |
19%
|
| Country | CH |
| Market Cap | 200.4B CHF |
| Net Margin |
20%
|
| Country | UK |
| Market Cap | 162.7B GBP |
| Net Margin |
13%
|
| Country | CH |
| Market Cap | 179.9B CHF |
| Net Margin |
35%
|
| Country | IE |
| Market Cap | 146B USD |
| Net Margin |
-126%
|
Jiangsu Nhwa Pharmaceutical Co Ltd
Glance View
Jiangsu Nhwa Pharmaceutical Co., Ltd. engages in the pharmaceutical production, research and development, and sales. The company is headquartered in Xuzhou, Jiangsu and currently employs 4,732 full-time employees. The company went IPO on 2008-07-23. The firm offers its pharmaceutical products under four categories, which consist of anesthetic medicines, including midazolam injections and etomidate fat emulsion pharmaceutical preparations injections; psychiatric medicines, including risperidone tablets and others; neurological medicines, including gabapentin capsules and others; bulk drugs, including fenofibrate and miconazole nitrate. The firm is also engaged in the pharmaceuticals trading business. Through its subsidiaries, the Company is also engaged in the Internet medical businesses. The firm distributes its products within domestic market and to overseas markets.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Jiangsu Nhwa Pharmaceutical Co Ltd's most recent financial statements, the company has Net Margin of 20.7%.
You don't have any saved screeners yet
